• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶 - 抗凝血酶III复合物及纤溶酶 - α2 - 纤溶酶抑制物复合物升高在非创伤性蛛网膜下腔出血急性期的意义

Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.

作者信息

Itoyama Y, Fujioka S, Takaki S, Morioka M, Hide T, Ushio Y

机构信息

Section of Neurosurgery, Saiseikai Kumamoto Hospital, Japan.

出版信息

Neurosurgery. 1994 Dec;35(6):1055-60. doi: 10.1227/00006123-199412000-00006.

DOI:10.1227/00006123-199412000-00006
PMID:7533897
Abstract

Thrombin-antithrombin III complex (TAT) and plasmin-alpha 2-plasmin inhibitor complex (PIC) were examined in the acute stage in 51 patients with nontraumatic subarachnoid hemorrhage. TAT and PIC values were correlated with severity at the time of onset and with outcome. In the patients whose TAT levels were 25 ng/ml or more and PIC levels were 3.0 micrograms/ml or more (n = 16), only 25% had a good or fair outcome. In the patients with TAT levels less than 25 ng/ml or PIC levels less than 3.0 micrograms/ml (n = 35), on the other hand, 82.9% had a good or fair outcome. There were no significant differences in TAT and PIC levels between patients who experienced arterial spasm and those who did not. These results indicate that TAT and PIC values may reflect the severity of the brain damage induced by subarachnoid hemorrhage. It is speculated that marked coagulation and fibrinolytic disorders occur in the acute stage of subarachnoid hemorrhage.

摘要

对51例非创伤性蛛网膜下腔出血患者急性期的凝血酶 - 抗凝血酶III复合物(TAT)和纤溶酶 - α2 - 纤溶酶抑制物复合物(PIC)进行了检测。TAT和PIC值与发病时的严重程度及预后相关。在TAT水平≥25 ng/ml且PIC水平≥3.0 μg/ml的患者(n = 16)中,仅有25%预后良好或尚可。另一方面,在TAT水平<25 ng/ml或PIC水平<3.0 μg/ml的患者(n = 35)中,82.9%预后良好或尚可。发生动脉痉挛的患者与未发生动脉痉挛的患者之间,TAT和PIC水平无显著差异。这些结果表明,TAT和PIC值可能反映蛛网膜下腔出血所致脑损伤的严重程度。据推测,蛛网膜下腔出血急性期会发生明显的凝血和纤溶障碍。

相似文献

1
Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.凝血酶 - 抗凝血酶III复合物及纤溶酶 - α2 - 纤溶酶抑制物复合物升高在非创伤性蛛网膜下腔出血急性期的意义
Neurosurgery. 1994 Dec;35(6):1055-60. doi: 10.1227/00006123-199412000-00006.
2
Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.糖尿病中血液凝固和纤维蛋白溶解的激活:通过血浆凝血酶 - 抗凝血酶III复合物和纤溶酶 - α2 - 纤溶酶抑制剂复合物水平进行评估
Thromb Res. 1989 Sep 15;55(6):727-35. doi: 10.1016/0049-3848(89)90303-4.
3
[Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].[正常和患病新生儿的抗凝血酶III、凝血酶-抗凝血酶III复合物、α2纤溶酶抑制剂及纤溶酶-α2纤溶酶抑制剂复合物的血浆水平]
Rinsho Ketsueki. 1991 Jul;32(7):758-65.
4
Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.关于正常妊娠、分娩及产褥期子宫胎盘循环中激肽释放酶-激肽系统的凝血-纤溶系统研究。
Agents Actions Suppl. 1992;38 ( Pt 2):320-9.
5
Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.单胎妊娠和双胎妊娠中凝血酶 - 抗凝血酶复合物及α - 纤溶酶抑制物 - 纤溶酶复合物水平
Int J Clin Pract. 2006 Oct;60(10):1244-9. doi: 10.1111/j.1742-1241.2005.00785.x. Epub 2006 Mar 27.
6
Hemostasis in spontaneous subarachnoid hemorrhage.自发性蛛网膜下腔出血的止血作用
Neurosurgery. 1995 Aug;37(2):226-34. doi: 10.1227/00006123-199508000-00006.
7
Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
Thromb Res. 1996 Jun 1;82(5):409-15. doi: 10.1016/0049-3848(96)00090-4.
8
[Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].糖尿病肾病凝血-纤溶系统的研究——参考血浆凝血酶-抗凝血酶复合物及α2纤溶酶抑制物
Nihon Jinzo Gakkai Shi. 1990 Sep;32(9):995-9.
9
[Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].[肾病综合征中凝血酶 - 抗凝血酶III复合物及纤溶酶α2 - 纤溶酶抑制物复合物的浓度]
Nihon Jinzo Gakkai Shi. 1991 Jul;33(7):653-8.
10
[Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].[凝血酶 - 抗凝血酶III复合物及纤溶酶 - α2纤溶酶抑制物复合物在慢性肝病中的临床意义]
Nihon Shokakibyo Gakkai Zasshi. 1990 Sep;87(9):1837-45.

引用本文的文献

1
The Woven Endobridge as a treatment for acutely ruptured aneurysms: A review of the literature.Woven Endobridge 治疗急性破裂动脉瘤:文献回顾。
Interv Neuroradiol. 2021 Oct;27(5):602-608. doi: 10.1177/1591019921991397. Epub 2021 Jan 28.
2
Intrasaccular Flow Disruption in Acutely Ruptured Aneurysms: A Multicenter Retrospective Review of the Use of the WEB.急性破裂动脉瘤的囊内血流阻断:关于WEB使用情况的多中心回顾性研究
AJNR Am J Neuroradiol. 2015 Sep;36(9):1721-7. doi: 10.3174/ajnr.A4347. Epub 2015 Jul 2.
3
Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review.动脉瘤性蛛网膜下腔出血后迟发性脑缺血中的止血与纤溶:一项系统评价
J Cereb Blood Flow Metab. 2015 May;35(5):724-33. doi: 10.1038/jcbfm.2015.13. Epub 2015 Feb 18.
4
Safety of preprocedural antiplatelet medication in coil embolization of ruptured cerebral aneurysms at the acute stage.急性破裂脑动脉瘤弹簧圈栓塞术中术前抗血小板药物的安全性
Interv Neuroradiol. 2014 Jul-Aug;20(4):413-7. doi: 10.15274/INR-2014-10035. Epub 2014 Aug 28.
5
Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.颅内出血患者的脑缺血:积极诊断管理的病理生理推理
Neuroradiol J. 2013 Dec;26(6):610-28. doi: 10.1177/197140091302600603. Epub 2013 Dec 18.
6
Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage.蛛网膜下腔出血患者凝血和纤溶系统的变化。
Neurol Med Chir (Tokyo). 2014 Jun 17;54(6):457-64. doi: 10.2176/nmc.oa2013-0006. Epub 2013 Dec 5.